Evidence map›Paper›PMID 17129366›Full record

ArticleBMC infectious diseases2006

Novel mutation of the PRNP gene of a clinical CJD case.

Konstantia Kotta, Ioannis Paspaltsis, Sevasti Bostantjopoulou, Helen Latsoudis, Andreas Plaitakis, Dimitrios Kazis, John Collinge, Theodoros Sklaviadis

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Genetic PrP Prion Diseases.Cold Spring Harbor perspectives in biology · 2018
    Review
  4. Prion disease.Handbook of clinical neurology · 2018
    Review
  5. Hereditary Human Prion Diseases: an Update.Molecular neurobiology · 2017
    Review
  6. Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2017
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Konstantia KottaPrion Disease Group, Laboratory of Pharmacology, School of Pharmacy, Aristotle University of Thessaloniki, Thessaloniki, Greece. ntina_kotta@yahoo.com <ntina_kotta@yahoo.com>
Ioannis Paspaltsis
Sevasti Bostantjopoulou
Helen Latsoudis
Andreas Plaitakis
Dimitrios Kazis
John Collinge
Theodoros Sklaviadis
Aristotle University of Thessaloniki · GRG. Papanikolaou General Hospital · GRUniversity of Crete · GRNational Hospital for Neurology and Neurosurgery · GB

Funding

Medical Research Council MC_U123160657Medical Research Council MC_U123192748
6 · The paper itself

Abstract

backgroundTransmissible spongiform encephalopathies (TSEs), a group of neurodegenerative diseases, are thought to be caused by an abnormal isoform of a naturally occurring protein known as cellular prion protein, PrPC. The abnormal form of prion protein, PrPSc accumulates in the brain of affected individuals. Both isoforms are encoded by the same prion protein gene (PRNP), and the structural changes occur post-translationally. Certain mutations in the PRNP gene result in genetic TSEs or increased susceptibility to TSEs. CASE PRESENTATION: A 70 year old woman was admitted to the hospital with severe confusion and inability to walk. Relatives recognized memory loss, gait and behavioral disturbances over a six month period prior to hospitalization. Neurological examination revealed Creutzfeldt-Jakob disease (CJD) related symptoms such as incontinence, Babinski sign and myoclonus. EEG showed periodic sharp waves typical of sporadic CJD and cerebrospinal fluid analysis (CSF) was positive for the presence of the 14-3-3-protein. As the disease progressed the patient developed akinetic mutism and died in the tenth month after onset of the disease symptoms. Unfortunately, no autopsy material was available. PRNP sequencing showed the occurrence of a point mutation on one allele at codon 193, which is altered from ACC, coding for a threonine, to ATC, encoding an isoleucine (T193I).

conclusionHere we report a novel mutation of the PRNP gene found in an elderly female patient resulting in heterozygosity for isoleucine and threonine at codon 193, in which normally homozygosity for threonine is expected (T193). The patient presented typical clinical symptoms of CJD. EEG findings and the presence of the 14-3-3 protein in the CSF, contributed to CJD diagnosis, allowing the classification of this case as a probable CJD according to the World Health Organization (WHO) accepted criteria.

Indexed as

14-3-3 ProteinsAgedCreutzfeldt-Jakob SyndromeFemaleHumansMutationPrionsSequence Analysis, DNA14-3-3 ProteinsPrions

Identifiers

PMID17129366
PMCPMC1693557
OpenAlexW2100624095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.